Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38212126)

  • 1.
    Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 and CCL5 in metastatic colorectal cancer.
    Schlechter BL; Stebbing J
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38719543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial.
    Suenaga M; Stintzing S; Cao S; Zhang W; Yang D; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Schirripa M; Soni S; Barzi A; Heinemann V; Lenz HJ
    Eur J Cancer; 2019 Jan; 107():100-114. PubMed ID: 30554073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
    Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
    Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
    Suenaga M; Cao S; Zhang W; Yang D; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Schirripa M; Soni S; Barzi A; Yamaguchi T; Lenz HJ
    Int J Cancer; 2019 May; 144(10):2567-2577. PubMed ID: 30411783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
    Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Ning Y; Cremolini C; Antoniotti C; Borelli B; Mashima T; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Lonardi S; Yamaguchi T; Falcone A; Loupakis F; Lenz HJ
    Clin Colorectal Cancer; 2018 Jun; 17(2):e395-e414. PubMed ID: 29606345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
    Aldinucci D; Casagrande N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.
    Gao LF; Zhong Y; Long T; Wang X; Zhu JX; Wang XY; Hu ZY; Li ZG
    J Exp Clin Cancer Res; 2022 Mar; 41(1):81. PubMed ID: 35241150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.
    Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J
    Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
    Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
    Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
    Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
    Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
    Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential to target CCL5/CCR5 in breast cancer.
    Velasco-Velázquez M; Xolalpa W; Pestell RG
    Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphism at
    Batista AM; Alvarado-Arnez LE; Alves SM; Melo G; Pereira IR; Ruivo LAS; da Silva AA; Gibaldi D; da Silva TDESP; de Lorena VMB; de Melo AS; de Araújo Soares AK; Barros MDS; Costa VMA; Cardoso CC; Pacheco AG; Carrazzone C; Oliveira W; Moraes MO; Lannes-Vieira J
    Front Immunol; 2018; 9():615. PubMed ID: 29696014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.
    Zumwalt TJ; Arnold M; Goel A; Boland CR
    Oncotarget; 2015 Feb; 6(5):2981-91. PubMed ID: 25671296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
    Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
    Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
    Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.